A Phase 3 trial evaluating the efficacy, duration of effect, and safety of DaxibotulinumtoxinA for Injection in the treatment of cervical dystonia

被引：0
|
作者：
Jankovic, J.
Comella, C.
Hauser, R.
Patel, A.
Gross, T.
Rubio, R.
Vitarella, D.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
100
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [31] A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study
    Green, Jeremy B.
    Mariwalla, Kavita
    Coleman, Kyle
    Ablon, Glynis
    Weinkle, Susan H.
    Gallagher, Conor J.
    Vitarella, Domenico
    Rubio, Roman G.
    DERMATOLOGIC SURGERY, 2021, 47 (01) : 42 - 46
  • [32] Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency
    Kessler, KR
    Skutta, M
    Benecke, R
    JOURNAL OF NEUROLOGY, 1999, 246 (04) : 265 - 274
  • [33] Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency
    Kirn R. Kessler
    Michael Skutta
    R. Benecke
    Journal of Neurology, 1999, 246 : 265 - 274
  • [34] Efficacy and safety of a new botulinum toxin type A free of complexing proteins in treatment of cervical dystonia
    Benecke, R
    MOVEMENT DISORDERS, 2004, 19 : S110 - S111
  • [35] Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal
    Marsili, Luca
    Bologna, Matteo
    Jankovic, Joseph
    Colosimo, Carlo
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 695 - 705
  • [36] Comparison of the safety and efficacy of botulinum toxin type-A and anticholinergics in the treatment of cervical dystonia patients
    Relja, M.
    Bozikov, J.
    MOVEMENT DISORDERS, 2015, 30 : S520 - S520
  • [37] Efficacy and Safety of Fospropofol Disodium for Injection in General Anesthesia Induction for Adult Patients: A Phase 3 Trial
    Wu, Chao-Meng
    Zhang, Wen-Sheng
    Liu, Jin
    Zhang, Wei-Yi
    Ke, Bo-Wen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] PRISM 301: AN OPEN-LABEL, RANDOMIZED, PHASE 3 CLINICAL TRIAL EVALUATING EFFICACY AND SAFETY OF PEGVALIASE FOR THE TREATMENT OF ADULTS WITH PHENYLKETONURIA
    Longo, Nicola
    Amato, Stephen
    Vocldey, Jerry
    Wierenga, Klaas
    Li, Hong
    Bilder, Deborah
    Burton, Barbara
    Dimmock, David
    Harding, Cary
    Posner, John
    Thomas, Janet A.
    Zori, Roberto
    Greblikas, Feriandas
    Gu, Zhonghua
    Merilainen, Markus
    Weng, Haoling H.
    Levy, Harvey
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) : 268 - 268
  • [39] Efficacy and Safety of ABP-450 (PrabotulinumtoxinA) in Adults With Cervical Dystonia: Results From the Open-label Extension of a Phase 2 Trial
    Jankovic, Joseph
    Oh, Chad
    Liu, Yan
    Abdul-Musawir, Najeebah
    Comella, Cynthia
    TOXICON, 2024, 237 : 36 - 37
  • [40] Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm
    Bihari, K
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (03) : 433 - 438
12345